Previous 10 | Next 10 |
A look at the top 10 most actives in the United States Soligenix Inc. (SNGX) rose 127.5% to $0.8782 on volume of 62,157,057 shares Trio Petroleum Corp. (TPET) rose 8.0% to $0.5571 on volume of 48,902,033 shares Organovo Holdings Inc. (ONVO) rose 36.3% to $1.3769 on volume of 34,819,187 sh...
2024-04-15 08:21:07 ET More on Pre-market losers & stocks. OncoCyte Corporation (OCX) Q4 2023 Earnings Call Transcript Monogram Orthopaedics, Inc. (MGRM) Q4 2023 Earnings Call Transcript Monogram Orthopaedics, Inc. 2023 Q4 - Results - Earnings Call Presentation ...
Trial did not meet pre-defined stopping criteria at the interim analysis; Marinus has completed RAISE enrollment at approximately 100 patients with topline results expected summer 2024 Future development of IV ganaxolone in refractory status epilepticus to be assessed following review of ...
2024-04-04 17:29:32 ET Gainers: Candel Therapeutics ( CADL ) +38% . Grindrod Shipping ( GRIN ) +28% . AngioDynamics ( ANGO ) +14% . Petco Health and Wellness Company ( WOOF ) +7% . Marinus Pharmaceuticals ( MRNS ) +5% . ...
2024-03-28 17:15:02 ET Oppenheimer analyst issues PERFORM recommendation for MRNS on March 28, 2024 03:28PM ET. The previous analyst recommendation was Perform. MRNS was trading at $9.04 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cur...
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to developing and commercializing innovative therapeutics to treat seizure disorders, today affirmed its commitment to defending its patent portfolio amidst an Inter Partes Review (IPR) challenge of U.S. Patent 11,...
2024-03-24 08:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-14 06:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-05 21:29:12 ET Start Time: 16:30 End Time: 17:36 Marinus Pharmaceuticals, Inc. (MRNS) Q4 2023 Earnings Conference Call March 05, 2024, 16:30 PM ET Company Participants Scott Braunstein - CEO and Chairman Christy Shafer - Chief Commercial Officer J...
2024-03-05 16:42:18 ET Gainers: Ebang International Holdings ( EBON ) +17% . CrowdStrike Holdings ( CRWD ) +17% . Couchbase ( BASE ) +14% . SOPHiA GENETICS ( SOPH ) +6% . Expensify ( EXFY ) +5% . Losers: ODDITY Tech...
News, Short Squeeze, Breakout and More Instantly...
Marinus Pharmaceuticals Inc. Company Name:
MRNS Stock Symbol:
NASDAQ Market:
Marinus Pharmaceuticals Inc. Website:
Enrollment complete in Phase 3 TrustTSC trial with topline data anticipated in the first half of Q4 2024 USPTO grants additional method of use patent for ganaxolone in TSC Marinus Pharmaceuticals , Inc. (Nasdaq:MRNS), a pharmaceutical company dedicated to the development of ...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
ZTALMY ® (ganaxolone) Q1 2024 net product revenue of $7.5 million representing strong growth of 125% versus Q1 2023 Increased full year 2024 projected U.S. ZTALMY net product revenues to between $33 and $35 million Enrollment to be completed mid-May in the Phase 3 TrustTSC trial ...